Novartis to Acquire Avidity Biosciences for About $12B (Connecting the Dots: Novartis, The FDA, The Conference Board, The Committee for Economic Development, Letitia James & Soros Funding, All Networking)
Newsmax.com
Sunday,
26 October 2025 07:03 PM EDT
Swiss
drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech firm
Avidity Biosciences for about $12 billion in cash.
Avidity
stockholders will receive $72 per share in cash, representing a premium of 46%
to the company's closing on Friday.
Under
the terms of agreement, Avidity will separate its early-stage precision
cardiology programs into a new company called Spinco.
Novartis
has been actively striking deals in 2025 as it looks to bolster its drug
pipeline and drive future growth, and the Financial Times reported in August
that the Swiss drugmaker had approached Avidity Biosciences for a potential
takeover offer.
Connecting
the Dots:
Novartis
Corporation is a U.S. subsidiary of Novartis AG and a
member of the Pharmaceutical Research and Manufacturers of America.
Akin,
Gump, Strauss, Hauer & Feld, LLP is the lobby firm for the Novartis
Corporation and the Pharmaceutical Research and Manufacturers of
America.
James F. Collins was
a senior advisor for Akin, Gump, Strauss, Hauer & Feld, LLP,
and is a senior associate at the Carnegie Endowment for International
Peace (think tank).
William W. George is
a trustee at the Carnegie Endowment for International Peace (think
tank) and was a director at Novartis AG.
Open Society Foundations was a funder
for the Carnegie Endowment for International Peace (think tank).
George Soros is the founder & chairman
for the Open Society Foundations and was the chairman for the Foundation
to Promote Open Society.
Foundation to Promote Open Society was a funder for
the Carnegie Endowment for International Peace (think tank).
Donald Kennedy was
a trustee at the Carnegie Endowment for International Peace (think
tank) and a commissioner for the U.S. Food and Drug Administration
(FDA).
Carnegie
Endowment for International Peace (think tank) was a
funder for the Nuclear Threat Initiative (think tank).
Margaret A.
Hamburg is a VP for the Nuclear Threat Initiative (think tank),
and the commissioner for the U.S. Food and Drug Administration (FDA).
Mark B. McClellan was
a commissioner for the U.S. Food and Drug Administration (FDA) and a
senior fellow at the Brookings Institution (think tank).
Foundation to Promote Open Society was a funder for
the Brookings Institution (think tank).
George Soros was the chairman for the Foundation
to Promote Open Society.
Ann M. Fudge is a
trustee at the Brookings Institution (think tank) and a director
at Novartis AG.
Klaus Kleinfeld is
a trustee at the Brookings Institution (think tank) and a trustee
at the Conference Board (think tank).
Marjorie M.T. Yang is a director at Novartis AG and was a trustee at the Conference Board.
George S. Barrett is a vice chairman for the Conference Board
and a trustee at the Committee for Economic Development.
Alan M. Dachs is
a chairman emeritus for the Conference Board and a trustee at
the Committee for Economic Development.
Edward B. Rust Jr. is
a trustee at the Conference Board and a trustee at the Committee
for Economic Development.
Samuel A.
DiPiazza Jr. is a trustee at the Conference Board and
a trustee at the Committee for Economic Development.
Ronald A. Williams is
a vice chairman for the Conference Board and a trustee at
the Committee for Economic Development.
Roger W.
Ferguson Jr. is a chairman for the Conference Board and
a trustee at the Committee for Economic Development.
Letitia James is the chair for the Committee on Economic
Development and the Attorney General of New York.
Carol A. Melton was
a trustee at the Committee for Economic Development and a
director at the Economic Club of Washington.
Robert G.
Liberatore was a trustee at the Committee for Economic
Development and a director at the Economic Club of Washington.
David M.
Rubenstein is the president of the Economic Club of Washington
and a co-chairman for the Brookings Institution (think
tank).
Ann M. Fudge is a
trustee at the Brookings Institution (think tank), and a director
at Novartis AG.
Foundation to Promote Open Society was a funder for
the Brookings Institution (think tank).
George Soros was the chairman for
the Foundation to Promote Open Society.
Mark B. McClellan was
a senior fellow at the Brookings Institution (think tank) and a
commissioner for the U.S. Food and Drug Administration (FDA).
Ann M. Fudge is a
trustee at the Brookings Institution (think tank), and a director
at Novartis AG.
Vernon E. Jordan
Jr. is an honorary trustee at the Brookings Institution (think
tank), a senior counsel for Akin, Gump, Strauss, Hauer & Feld,
LLP and was the president of the Economic Club of Washington.
Akin,
Gump, Strauss, Hauer & Feld, LLP is the lobby firm for the Novartis
Corporation and the Pharmaceutical Research and Manufacturers of
America.
Novartis
Corporation is a U.S. subsidiary of Novartis AG and a
member of the Pharmaceutical Research and Manufacturers of America.
William W. George was
a director at Novartis AG and is a trustee at the Carnegie
Endowment for International Peace (think tank).
Open Society Foundations was a funder for
the Carnegie Endowment for International Peace (think tank).
George Soros is the founder
& chairman for the Open Society Foundations and was the
chairman for the Foundation to Promote Open Society.
Foundation to Promote Open Society was a funder
for the Carnegie Endowment for International Peace (think tank).
Donald Kennedy was
a trustee at the Carnegie Endowment for International Peace (think
tank) and a commissioner for the U.S. Food and Drug Administration
(FDA).
Carnegie
Endowment for International Peace (think tank) was a
funder for the Nuclear Threat Initiative (think tank).
Margaret A.
Hamburg is a VP for the Nuclear Threat Initiative (think tank),
and the commissioner for the U.S. Food and Drug Administration (FDA).
Mark B. McClellan was
a commissioner for the U.S. Food and Drug Administration (FDA) and a
senior fellow at the Brookings Institution (think tank).
Foundation to Promote Open Society was a funder
for the Brookings Institution (think tank).
George Soros was the chairman for the Foundation
to Promote Open Society.
Ann M. Fudge is a
trustee at the Brookings Institution (think tank) and a director
at Novartis AG.
Resources:
Past Research
Neurologist
Claims There Is No Such Thing as ADHD (Past
Research on Novartis)
Thursday,
March 13, 2014
https://thesteadydrip.blogspot.com/2014/03/neurologist-claims-there-is-no-such.html
Trump:
Biden Judge Can't Save Comey (Connecting the Dots: Judge Michael Nachmanoff,
FBI, James Comey, Joe Biden, Lisa Murkowski, Susan Collins, Letitia James, Mark
Warner & Soros Funding, All Networking) (Past
Research on Letitia James, the Committee for Economic Development & the Economic
Club of Washington)
Friday,
September 26, 2025
https://thesteadydrip.blogspot.com/2025/09/trump-biden-judge-cant-save-comey.html
Fed/Duke
Survey: CFO Optimism Drops on Tariffs (Connecting the Dots: Duke University,
Conference Board, Federal Reserve, Obamacare, Committee for Economic
Development, The Commercial Club of Chicago & Soros Funding, All
Networking) (Past Research on the Committee for
Economic Development & the Conference Board)
Monday,
March 31, 2025
https://thesteadydrip.blogspot.com/2025/03/fedduke-survey-cfo-optimism-drops-on.html
Novartis
Seeks COVID-19 Antiviral Candidate Authorization (Past
Research on Novartis)
Sunday,
April 24, 2022
https://thesteadydrip.blogspot.com/2022/04/novartis-seeks-covid-19-antiviral.html
No comments:
Post a Comment